ArticleJournal of translational medicine2026
V7-DiVA: a feature-based Deep MIL colorectal whole-slide histopathology research platform with blinded external image-input validation.
Article in Journal of translational medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Beyond the barrier: Engineering the tumor-immune-soil nexus-a mechanistic blueprint for integrating Traditional Chinese Medicine with immunotherapy in metastatic colorectal cancer.Medical oncology (Northwood, London, England) · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundWhole-slide imaging offers a route to scalable computational assessment of colorectal histology, but models developed on public cohorts may not transfer reliably to real-world clinical practice. We developed V7-DiVA (Version 7 Deep Integrated Visual Analytics), a feature-based, gated-attention deep multiple-instance learning (MIL) research platform that links slide-level classification with quality metadata and reviewable image regions.
methodsPatch-level feature vectors were generated using a supervised feature extractor developed on NCT-CRC-HE-100K and independently evaluated on CRC-VAL-HE-7K. They were organized as 95-dimensional vectors comprising an 82-dimensional supervised feature core, tumor-evidence and morphology scores, coordinates, tissue fraction, and focus-quality features. The primary gated-attention Deep MIL model was developed on 1,972 TCGA-COAD/READ slides from 631 cases using case-grouped fivefold cross-validation. The trained model and its prespecified preprocessing specification, including standardization parameters estimated from TCGA, feature order, and inference rules, were then applied without modification to 300 de-identified local WSIs (150 malignant and 150 normal/non-neoplastic; one slide per case). A same-feature Transformer aggregator and a separately trained public-data-only CTransPath branch were secondary comparators. Scores were generated before reference-label mapping, and no local slide was used for model fitting, calibration, or threshold optimization.
resultsPatch-level tumor-evidence AUROCs were 0.997 on NCT-CRC-HE-100K and 0.987 on CRC-VAL-HE-7K. The primary Deep MIL model yielded a case-grouped TCGA development AUROC of 0.991 (95% CI 0.980-0.999) and an external AUROC of 0.918 (0.882-0.950) after transfer without refitting. Slide-level quality metadata characterized differences in tissue extent and focus and provided review cues for misclassified slides.
conclusionsV7-DiVA places feature-based gated-attention Deep MIL at the center of an integrated colorectal WSI research workflow. By learning from slide-level labels, aggregating variable-length feature bags, and retaining instance-level attention weights for review, the primary branch directly links weakly supervised learning to auditable image evidence. Its performance after transfer without refitting supports further multicenter evaluation, while the Transformer and CTransPath analyses provide complementary evidence across alternative aggregation and representation strategies. Independent calibration, broader diagnostic spectra, and prospective reader studies are required before clinical use.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.